82 G. Taino et al.: Radioprotection 2025, 60( 1), 76 – 83
Alberg AJ, Brock MV, Samet JM. 2005. Epidemiology of lung cancer: looking to the future. J Clin Oncol 23: 3175 – 3185.
Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. 2007. Computed tomography screening and lung cancer outcomes. JAMA 297: 953 – 961.
Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol. 2012 Sep; 138( 9): 1475-86. doi: 10.1007 / s00432-012-1228-9.
Bertho JM, Habib B. 2023. Radiation protection is an attitude. Radioprotection 58: 77 – 78.
Bianchi F, Nicassio F, Marzi M, Belloni E, Dall’ olio V, Bernard L, et al. 2011. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Molec Med 3: 495 – 503.
Bigbee WL, Gopalakrishnan V, Weissfeld JL, Wilson DO, Dacic S, Lokshin AE, et al. 2012. A multiplexed serum biomarkers immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening. J Thorac Oncol 7: 698 – 708.
Bochicchio F, Campos-Venuti G, Piermattei S, Nuccetelli C, Risica S, Tommasino L, et al. 2005. Annual average and seasonal variations of residential radon concentration for all the Italian regions. Radiat Measur 40: 686 – 694.
Blanchon T, Bréchot JM, Grenier PA, Ferretti GR, Lemarié E, Milleron B, et al. Dépiscan Group. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan( LDCT) and chest X-ray( CXR). Lung Cancer. 2007 Oct; 58( 1): 50-8. doi: 10.1016 / j. lungcan. 2007.05.009.
Bochicchio F, Forastiere F, Farchi S, Quarto M, Axelson O. 2005. Residential radon exposure, diet and lung cancer: a case-control study in a Mediterranean region. Int J Cancer 114: 983 – 991.
Carrola J, et al. 2011. Metabolic signatures of lung cancer in biofluids, NMR-based metabonomics of urine. J Proteome Res 10: 221 – 230.
Chapman CJ, et al. 2012. Early CDT-Lung test: improved clinical utility through additional autoantibody assays. Tumor Biol 33: 1319 – 1326.
Chu GCW, Lazare K, Sullivan F. 2018. Serum and blood based biomarkers for lung cancer screening: a systematic review. BMC Cancer 18( 1): 181.
Crispo A, Brennan P, Jockel KH, et al. 2004. The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br J Cancer 91: 1280 – 1286.
Darby S, Hill D, Auvinen A, et al. 2005. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies BMJ 330( 7485): 223. Directive 97 / 43 / Euratom, based on ICRP pubblication 60, 1990 Directive 2013 / 59 / Euratom. European Commission, Directorate-General for Environment. Radiological protection principles concerning the natural radioactivity of building materials. Publications Office, Vol. 112, Radiation Protection 2000.
Epicentro ISS( Italian governmental Health Insitute). Radon � Epidemiological features- Available at: https:// www. epicentro. iss. it / radon / epidemiologia #: ∼: text = L’ Iss % 20ha % 20stimato % 20che, che % 20ne % 20moltiplica % 20gli % 20effetti IARC. 2013. CancerBase No. 11. Lyon, International Agency for
Research on Cancer.
Gasparri R et al. 2016. Volatile signature for early diagnosis of lung cancer. J Breath Res 10: 016007.
Gasparri R, Romano R, Sedda G, Borri A, Petrella F, Galetta D, et al. 2017. Diagnostic biomarkers for lung cancer prevention. J. Breath Res 12( 2028): 027111.
Gharibvand L, Shavlik D, Ghamsary M, et al. 2017. The Association between ambient fine particulate air pollution and lung cancer incidence: results from the AHSMOG-2 study. Environ Health Perspect 125( 3): 378 – 384.
Haznadar M, et al. 2016. Urinary metabolite risk biomarkers of lung cancer: a prospective cohort study, Cancer Epidemiol Biomarkers Prev 25: 978 – 986.
Henschke CI, McCauley DI, Yankelevitz DF, et al. 1999. Early lung cancer action project: overall design and findings from baseline screening. Lancet 354( 9173): 99 – 105.
Henschke CI, Yankelevitz DF, et al. 2006. International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355( 17): 1763 – 1771.
IARC. 1988. Man-Made Mineral Fibres and Radon. Lyon, France. IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans. IARC; 1988; Volume 43.
Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, et al. DANTE Study Group. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med. 2009 Sep 1; 180( 5): 445-53. doi: 10.1164 / rccm. 200901-0076OC.
ICRP. 2007. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP 37( 2 – 4).
ICRP. 2017. Occupational Intakes of Radionuclides: Part 3. ICRP
Publication 137. Ann ICRP 46( 3 / 4). Italian Law, Legislative Decree of 26 May 2000 no. 187. Italian Law, Legislative Decree of 26 May 2000 no. 241 Italian Law, Legislative Decree of 9 April 2008 no. 81, Articolo 17. Italian Law, Legislative Decree of 31 July 2020 no. 101, Titolo II,
Articolo 7, comma 40. Italian Law, Legislative Decree of 31 July 2020 no. 101, Titolo II,
Articolo 7, comma 40. Italian Law Legislative Decree of 31 July 2020 no. 101, Titolo IV,
Articolo 11.
Jett JR, Peek LJ, Fredericks L, Jewell W, Pingleton WW, JFR. R. 2014. Audit of the autoantibody test, EarlyCDT-lung, in 1600 patients: an evaluation of its performance in routine clinical practice. Lung Cancer( Amsterdam, Netherlands) 83( 1): 51 – 55.
Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS, Field RW, et al. 2005. Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology 16: 137 – 145.
Lopes Pegna A, Picozzi G, Falaschi F, Carrozzi L, Falchini M, Carozzi FM, et al. ITALUNG Study Research Group. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. J Thorac Oncol. 2013 Jul; 8( 7): 866-75. doi: 10.1097 / JTO. 0b013e31828f68d6.
Lorenzo-González M, Torres-Durán M, Barbosa-Lorenzo R, Provencio-Pulla M, Barros-Dios JM, Ruano-Ravina A. 2019. Radon exposure: a major cause of lung cancer. Expert Rev Respir Med 13( 9): 839 – 850.
Montani F, Marzi MJ, Dezi F, Dama E, Carletti RM, Bonizzi G, et al. miR-Test: a blood test for lung cancer early detection. J Natl Cancer Inst 107( 6): djv063.